Body mass does not affect the remission of psoriatic arthritis patients on anti-TNF-α therapy

Author： Iannone F Fanizzi R Scioscia C Anelli MG Lapadula G

ISSN： 0300-9742

Source： Scandinavian Journal of Rheumatology, Vol.42, Iss.1, 2013-01, pp. : 41-44

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Surgery in rheumatoid arthritis patients under anti-TNF-α therapy: what is the risk?

By Wendling Daniel

Clinical Rheumatology, Vol. 26, Iss. 8, 2007-08 ,pp. : 1396-1397

Springer Publishing Company

Access to resources Recommend Favorite

The effect of anti-TNF-α vs. DMARDs on fatigue in rheumatoid arthritis patients

By van Hoogmoed D Fransen J Repping-Wuts H Spee L Bleijenberg G van Riel PLCM

Scandinavian Journal of Rheumatology, Vol. 42, Iss. 1, 2013-01 ,pp. : 15-19

Informa Healthcare

Access to resources Recommend Favorite

Anti-TNF-α therapy in membranous glomerulonephritis

By Santoro Domenico Postorino Adele Costantino Giuseppe Savica Vincenzo Bellinghieri Guido

Clinical Kidney Journal, Vol. 5, Iss. 5, 2012-10 ,pp. : 487-488

Oxford University Press

Access to resources Recommend Favorite

Lethal acute respiratory distress syndrome during anti-TNF-α therapy for rheumatoid arthritis

By Zimmer Christian Beiderlinden Martin Peters Jürgen

Clinical Rheumatology, Vol. 25, Iss. 3, 2006-05 ,pp. : 430-432

Springer Publishing Company

Access to resources Recommend Favorite

Treatment with anti-TNF-α antibody infliximab reduces serum IL-15 levels in patients with rheumatoid arthritis

By Kageyama Yasunori Takahashi Masaaki Torikai Eiji Suzuki Motohiro Ichikawa Tetsuya Nagafusa Tetsuyuki Koide Yukio Nagano Akira

Clinical Rheumatology, Vol. 26, Iss. 4, 2007-04 ,pp. : 505-509

Springer Publishing Company

Access to resources Recommend Favorite